Navigation Links
Stem Cells Buy Freedom From Insulin for Type 1 Diabetics
Date:4/14/2009

patients have received transplantations of insulin-producing cells from a donor, but none have remained free of exogenous (outside) insulin for longer than five years, said Dr. Spyros Mezitis, an endocrinologist with Lenox Hill Hospital in New York City. This was because the body eventually started attacking those cells as well.

The current approach is more hopeful, because it involves the patient's own stem cells, not only bypassing the possibility of rejection but also allowing, theoretically, an unlimited number of future cells to be produced, he said.

A 2007 study by the same group of researchers had found that autologous (using the patients' own stem cells) nonmyeloablative hematopoietic stem cell transplantation (HSCT) allowed type 1 diabetes patients to revert to not using outside insulin, at least for a time.

"That was the first time in history we achieved normal blood sugar and A1c levels and were drug-free after one intervention," Burt said. "Otherwise, patients are stuck on insulin or islet transplant, but they still have to be on intensive immune suppression. On this treatment, they're on nothing. But the criticism was that maybe this insulin independence was a freak prolonged honeymoon period."

"It takes time for the body to attack and break down the insulin-producing cells," explained Mezitis. "So the cells continue producing insulin, then, as the body attacks the cells, they die out."

In this latest report, the authors found beta-cell improvements in 23 patients, aged 13 to 31, who were recently diagnosed with type 1 diabetes.

All participants underwent HSCT, which involved removing the patient's own blood stem cells then reinjecting them into the body.

Twenty patients were able to stop injecting insulin, 12 of them for a mean of 31 months. Eight patients had to start taking insulin again at a low dose.

Not only were blood sugar levels normalized among those individuals w
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Three Medical Centers Awarded Funds to Study Generation of Cardiac Muscle Cells
2. UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells
3. New alternative to biopsy detects subtle changes in cancer cells, Stanford study shows
4. UCSF team closer to creating safe embryonic-like stem cells
5. Stem Cells Spur New Eggs in Ovaries of Adult Mice
6. Stem Cells Repair Damaged Corneas in Mice
7. Molecule prompts damaged heart cells to repair themselves after a heart attack
8. Patient Movement Forms in Opposition to FDA Position that the Patient's Own Stem Cells are Drugs
9. Not just a long-distance relationship: Immune cells in skin fight off infection better than the rest
10. New technique invented to reveal pancreatic stem cells
11. JHU researcher discovers brain cells have memory
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stem Cells Buy Freedom From Insulin for Type 1 Diabetics
Stem Cells Buy Freedom From Insulin for Type 1 Diabetics
(Date:12/16/2009)... CLEVELAND -- December 16, 2009 -- Every year ... are diagnosed, and 57,000 patients die of the disease, ... cancer among adults, after lung cancer. , As researchers ... colorectal cancer -- simultaneously generating thousands of studies producing ... professor and researcher of cancer and genetics at Case ...
(Date:12/16/2009)... Immucor, Inc. (Nasdaq: BLUD ), a global leader ... industry, today announced that Paul D. Mintz, M.D. has ... director, effective January 1, 2010. ,, Dr. Mintz ... for more than 30 years. He is a tenured ... Virginia School of Medicine. He also serves as director ...
(Date:12/16/2009)... Allscripts (Nasdaq: MDRX ) announced today that ... three and six months ended November 30, 2009 ... 11, 2010. Allscripts management will host a conference ... and other information at 8:30 AM Eastern Standard ... http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, Allscripts fiscal second quarter earnings ...
(Date:12/16/2009)... Dec. 16 The most widely used human embryonic ... raises social justice questions that must be addressed to ... cell advances, according to a University of Michigan research ... kind, the U-M team analyzed 47 embryonic stem cell ... stem cell researchers. The scientists determined the genetic ancestry ...
(Date:12/16/2009)... HealthSciences Institute will sponsor a new learning ... organizations who serve individuals at risk of, ... health plan, medical home and other provider ... noncommercial webinars on topics, solutions and case ... care improvement. Each webinar will include a ...
Breaking Medicine News(10 mins):Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3Health News:Immucor Appoints New Board Director 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3
... Light of New Evidence Showing the,Benefits of UV ... Today, the Indoor,Tanning Association (ITA) launched an ... and criticizing,dermatologists and the sunscreen and cosmetics industries ... advertising blitz begins with a full-page print ad ...
... Md. (March 26, 2008) -- The American Physiological Society ... the 2008 Henry Pickering Bowditch Memorial Award for early-career ... 42 years whose accomplishments are both original and outstanding. ... a professor of pharmacology and toxicology, has focused her ...
... Visiprise, Inc., a leader in,manufacturing execution systems (MES) ... named to START-IT magazine,s START-IT 125 list., ... editors and editorial advisors,of START-IT magazine to recognize ... market., Visiprise,s flagship solution, Visiprise Manufacturing, is ...
... Needed, Experts Say, PHILADELPHIA, March 26 ... group of healthcare leaders based at the,University of ... convene a,special conference to address the national shortage ... cannot be maintained, let alone,expanded, unless we educate ...
... 26 WPCS International,Incorporated (Nasdaq: WPCS ... specialty communication systems and wireless infrastructure, has,announced ... awarded approximately,$12 million in new contracts., ... for The University of,Connecticut, The Mashantucket Pequot ...
... ... BIG HORN, Wyo., March 26 Gourmetceuticals, LLC, ... for use in foods and beverages, today announced ... booster, and,PPL-240, an antioxidant, will be presented at ...
Other Medicine News:Health News:Indoor Tanning Association Launches Campaign Attacking Melanoma Hype 2Health News:MSU professor earns Bowditch Award for work on hypertension 2Health News:MSU professor earns Bowditch Award for work on hypertension 3Health News:Visiprise Named One of the Top Manufacturing Technology Providers 2Health News:Council Calls on White House to Convene Conference on Physician and Nurse Supply 2Health News:WPCS Announces $12 Million in New Projects 2Health News:Gourmetceuticals to Present Data from Four Studies at Experimental Biology 2008 2
(Date:12/16/2009)... -- Sanofi Pasteur, the vaccines ... that it has entered into an exclusive, ... and commercialize its prophylactic vaccine against ... or MRSA. MRSA are responsible for ... to as multidrug-resistant Staphylococcus aureus ...
(Date:12/16/2009)... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a ... today announced top-line efficacy and safety results from ... the treatment of Peyronie,s disease. Peyronie,s disease is ... the shaft of the penis, which can distort ... impossible in advanced cases. The Phase 2b study, ...
(Date:12/16/2009)... WOONSOCKET, R.I., Dec. 16 CVS/pharmacy and ... stores are now offering H1N1 vaccine in 20 ... locations priority restrictions for receiving H1N1 vaccines continue, ... to be eligible to receive the shot while ... has been restocked and is available at MinuteClinic ...
Breaking Medicine Technology:Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 2Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 4BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4Atrial fibrillation in endurance athletes still poses problems for sports cardiologists 49549 1Atrial fibrillation in endurance athletes still poses problems for sports cardiologists 49549 2Atrial fibrillation in endurance athletes still poses problems for sports cardiologists 49549 3METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis 28SPPS 29 12714 1METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis 28SPPS 29 12714 2Does Location Affect Kids Weight 3F 49542 1Does Location Affect Kids Weight 3F 49542 2
... a study published in The American Journal of ... Clinic psychiatrist Mark Frye, M.D., attempted to identify what ... to experience treatment-emergent mania (TEM).Bipolar disorder, also known as ... mood instability that can be serious and disabling. The ...
... for Type 2 Diabetes-PLYMOUTH MEETING, Pa., Feb. 10 ... promising preliminary Phase 1b clinical data for trodusquemine (MSI-1436), ... lead drug candidate for the treatment of type 2 ... CEO of Genaera, presented data from the first of ...
Other Medicine Technology:Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder 2Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder 3Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436) 2Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436) 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: